Diseccionan la diversidad genética del cáncer de pulmón y ofrecen la imagen más detallada hasta la fecha de la metástasis de este tipo de cáncer. Los resultados presentan al cáncer como una ent...
Read moreInvestigadoras del Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, han identificado un perfil molecular en biopsia líquida (sangre) asociado con el riesgo de desarr...
Read moreAlmirall ha anunciado recientemente los resultados de un análisis secundario del programa en fase III (estudios ADvocate y ADhere) que ha demostrado que los pacientes tratados con lebrikizumab mejora...
Read moreLa anisometropía puede ser congénita, estando presente desde el nacimiento o bien adquirida, pudiendo ser secundaria a un traumatismo, patología ocular (catarata, queratocono...) o cirugía ocular ...
Read moreResearchers have combined results from two genome-wide association studies (GWAS) to find genetic variants, i.e., changes in the genome, associated with ADHD and life expectancy
Read moreThe project PhotoHeart aims to provide early and localized treatment after a heart attack to significantly reduce cardiac tissue damage, thus boosting patient recovery and minimizing future cardiac co...
Read moreWith artificial intelligence (AI) it is possible to apply more objective methods in the diagnosis of rare diseases. However, most AI-generated algorithms are based on databases of European populations...
Read moreThe research has focused on the study, using methods based on proteomics and immunohistochemistry techniques, to explore the extent of inflammatory and immune responses in subjects with CADASIL
Read moreIt has been launched a project to design a European database of molecular dynamics. Over the next three years, the scientists will lay the foundations for an infrastructure that optimises computationa...
Read moreIt has been identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor. SLFN 12 shuts down viral protein production and helps virus-infected cells to escape from anti-HIV the...
Read moreOryzon Genomics, S.A. a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the first ...
Read moreInvestigadores del Cima demuestran que oler esta sustancia modula el sistema inmune y mejora la cognición en modelos animales de esta enfermedad neurodegenerativa. Este estudio abre la puerta al desa...
Read more